NASDAQ NMS - GLOBAL MARKET · LAB
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Standard BioTools Inc

Standard BioTools Inc

Life Sciences Tools & Services
$0.6500
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
LAB
Standard BioTools Inc
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is LAB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading LAB catalysts
About Standard BioTools Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2011
Employees
389
Country
US

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.6500
Last session
Day high
$0.6500
Last session
Day low
$0.6500
Last session
Previous close
$0.6500
52W high
$1.68
-61.31% from high
52W low
$0.6463
0% of range
Market cap
$262.6M
P/E
3.47×
EPS
$0.0800
Beta
0.68
Shares out
392.6M
Avg volume
1.8M
VWAP
$0.6500
Last session
Price history computed in-house
1W
-1.81%
1M
-21.99%
3M
-38.68%
1Y
-47.58%
YTD
-49.22%
SMA 50 $0.8102 · below
SMA 200 $1.09 · below
52W position 0%

LAB overview

Veridion Score
45
Registered · 2026-08-24
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around LAB.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading LAB Form 4 filings
Public disclosures

Congress activity in LAB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for LAB in the cached public ledger.

Federal contracts

LAB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LAB in this window.
Lobbying spend

LAB lobbying filings, year to date.

Registered lobbying filings matched to Standard BioTools Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LAB in this window.
Loading news for LAB
Analyst ratings
Sovereign unlock shows live analyst consensus for LAB.
Options
Sovereign unlock shows live options positioning for LAB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.